Skip to content

To see whether Low dose magnesium sulphate can reduce haemodynamic changes associated with laryngoscopy and intubation response.

Attenuation of laryngoscopy and intubation response to different doses of IV MgSo4: A perspective randomized control trial in Tertiary care Hospital,Bhubaneswar - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072007
Enrollment
165
Registered
2024-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Magnesium sulphate: To see whether Low dose magnesium sulphate can reduce haemodynamic changes associated with laryngoscopy and intubation response. Control Intervention1: Magnesium sul

Sponsors

IMS and SUM Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pt. belonging to ASA 1 and 2, Pt. posted for elective cases.

Exclusion criteria

Exclusion criteria: Patients belonging to ASA 3 and 4, patients who are not willing to participate in the study, patients with neurological disorder and with past psychiatric illness, patients with cardiovascular disease, patients who can’t speak or understand English,Hindi or Odia, if laryngoscopy time more than 15 secs or more than one attempt of intubation

Design outcomes

Primary

MeasureTime frame
To compare in between different dose of IV MgSo4 in attenuation of laryngoscopy and intubation responseTimepoint: O,2,4,6,8 minutes

Secondary

MeasureTime frame
To compare any intra op arrhythmias, intra op hypotension and desaturationTimepoint: 0,2,4,6,8,10 mins

Countries

India

Contacts

Public ContactDebabrat nanda

Ims and Sum hospital

samal.rajib2013@gmail.com8763763798

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026